Table 4 Pelvic floor dysfunction assessment scale.
Group | Cases | PFDI-20 | t | P | PFIQ-7 | t | P | ||
|---|---|---|---|---|---|---|---|---|---|
Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | ||||||
Observation group | 263 | 46.63 ± 3.88 | 14.47 ± 1.28 | 127.652 | < 0.001 | 18.74 ± 3.56 | 9.56 ± 1.62 | 38.063 | < 0.001 |
Control group | 374 | 46.35 ± 9.92 | 23.29 ± 5.26 | 39.718 | < 0.001 | 18.55 ± 6.88 | 12.71 ± 3.15 | 14.926 | < 0.001 |
t | 0.435 | −26.639 | 0.411 | −14.889 | |||||
P | 0.664 | < 0.001 | 0.681 | < 0.001 | |||||